Sign in
The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes
Journal article   Peer reviewed

The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes

Aziz Nazha, David P Seastone, Michael Keng, Sean Hobson, Matt Kalaycio, Jaroslaw P Maciejewski and Mikkael A Sekeres
Leukemia & lymphoma, Vol.56(12), pp.3437-3439
2015
PMID: 25907427

Abstract

Humans Myelodysplastic Syndromes - diagnosis Myelodysplastic Syndromes - mortality Prognosis

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.103 Blood Disorders
1.103.155 Acute Myeloid Leukemia
Web Of Science research areas
Hematology
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details